Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
This article helps you decide between taxable and tax-exempt bond funds in retirement, outlining allocation strategies and tax considerations.
25,011 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...
Crypto markets are cooling as macro policy tightens and Bitcoin stalls on a breakout. This combination has led to a d...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
Two AI infrastructure players, CoreWeave and Nebius, face off as compute demand climbs. This guide breaks down backlo...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Memes have evolved from jokes into a serious branding engine. In 2026, chuck norris never dies: anchors licensing dea...
A strategic shift in how the government engages with industry is triggering a market rethink. The administration is t...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A wave of billionaire fund managers are boosting Amazon bets as AI hype collides with a value play. Pershing Square, ...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...